Michael Herrman
Geen lopende functies
Vermogen: 306 501 $ op 31-05-2024
Profiel
Michael R.
Herrman worked as the Head-Legal at Boehringer Ingelheim Corp.
from 2017 to 2019 and later as the Secretary, Executive VP & General Counsel at PetIQ, Inc. from 2019 to 2023.
He completed his undergraduate degree from the University of Connecticut and his graduate degree from Syracuse University College of Law and S.I.
Newhouse School of Public Communications.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PETIQ, INC. CLASS A
0.05% | 12-04-2024 | 14 764 ( 0.05% ) | 306 501 $ | 31-05-2024 |
Eerdere bekende functies van Michael Herrman
| Bedrijven | Functie | Einde |
|---|---|---|
| PETIQ, INC. | Algemeen Adviseur | 02-08-2023 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Directeur/Bestuurslid | 01-01-2017 |
Opleiding van Michael Herrman
| University of Connecticut | Undergraduate Degree |
| S.I. Newhouse School of Public Communications | Graduate Degree |
| Syracuse University College of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PETIQ, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
